In spite of its shortcomings, The reality that the coverage is being rolled out as a demo is really a constructive factor, reckons Michel Kazatchkine, a member of the Global Commission on Drug Coverage. The strongest method to encourage naysayers is through furnishing chilly, tricky, irrefutable proof, he suggests, and The simplest way to do that i